GGrantIndex
← Leaderboards

Priyamvada Acharya

Duke University

$21,922,845
Attributed
$29,990,359
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $13M · FY201925
$20M$15M$10M$5M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$51,521,510 · 9

By mechanism

U54$32,096,154 · 4
R01$12,536,838 · 3
U01$6,461,018 · 1
R21$427,500 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Structure

Research focus

StructureResolutionAntibodiesHiv-1Molecular ConformationNeutralizing AntibodyVirusVaccinesBindingExpectationCryoelectron MicroscopyEvolutionEpitopesInnovationViralMediatingGrantInsightExperimental StudyTechnologyInfectionComplexPropertyDesign

Grant awards (42)

Duke Center for HIV Structural Biology$4,534,742
U54 · FY2025 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,345,576
U01 · FY2025 · AI
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound$1,033,535
U54 · FY2025 · AI · contact PI
Structural definition of CD4-induced HIV-1 Env conformational changes required for infection$807,497
R01 · FY2025 · AI · contact PI
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike$739,280
R01 · FY2025 · AI · contact PI
Core 1 - Structural Biology Core$676,159
U54 · FY2025 · AI · contact PI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1$661,066
R01 · FY2025 · AI · contact PI
Administrative Core$446,355
U54 · FY2025 · AI · contact PI
Duke Center for HIV Structural Biology$5,412,818
U54 · FY2024 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,522,830
U01 · FY2024 · AI
Core 1 - Structural Biology Core$1,229,047
U54 · FY2024 · AI · contact PI
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound$1,189,016
U54 · FY2024 · AI · contact PI
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike$762,305
R01 · FY2024 · AI · contact PI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1$672,175
R01 · FY2024 · AI · contact PI
Administrative Supplement for U54 AI170752$590,000
U54 · FY2024 · AI · contact PI
Core 1 - Structural Biology Core$590,000
U54 · FY2024 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$535,920
U01 · FY2024 · AI
Administrative Core$480,790
U54 · FY2024 · AI · contact PI
Duke Center for HIV Structural Biology$5,488,457
U54 · FY2023 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,552,089
U01 · FY2023 · AI
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound$1,188,896
U54 · FY2023 · AI · contact PI
Core 1 - Structural Biology Core$1,111,515
U54 · FY2023 · AI · contact PI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection$770,818
R01 · FY2023 · AI · contact PI
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike$762,466
R01 · FY2023 · AI · contact PI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1$683,445
R01 · FY2023 · AI · contact PI
Administrative Core$472,559
U54 · FY2023 · AI · contact PI
Duke Center for HIV Structural Biology$5,505,134
U54 · FY2022 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,504,603
U01 · FY2022 · AI
Core 1 - Structural Biology Core$890,349
U54 · FY2022 · AI · contact PI
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound$870,076
U54 · FY2022 · AI · contact PI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection$779,673
R01 · FY2022 · AI · contact PI
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike$762,466
R01 · FY2022 · AI · contact PI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1$695,359
R01 · FY2022 · AI · contact PI
Administrative Core$386,706
U54 · FY2022 · AI · contact PI
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development$771,293
R01 · FY2021 · AI · contact PI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection$739,174
R01 · FY2021 · AI · contact PI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1$704,939
R01 · FY2021 · AI · contact PI
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection$201,250
R21 · FY2021 · AI · contact PI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection$733,183
R01 · FY2020 · AI · contact PI
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development$732,990
R01 · FY2020 · AI · contact PI
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection$226,250
R21 · FY2020 · AI · contact PI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection$758,709
R01 · FY2019 · AI · contact PI